Progenics, Nektar Still Halted; FDA Advisory Committee Expected To Conclude Thursday

By: via Benzinga
Progenics Pharmaceuticals (NASDAQ: PGNX) and Nektar Therapeutics (NASDAQ: NKTR) are halted as investors wait for the FDA panel's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.